Cargando…
An Expert, Multidisciplinary Perspective on Best Practices in Biomarker Testing in Intrahepatic Cholangiocarcinoma
Intrahepatic cholangiocarcinoma (iCCA) is a rare and aggressive malignancy that arises from the intrahepatic biliary tree and is associated with a poor prognosis. Until recently, the treatment landscape of advanced/metastatic iCCA has been limited primarily to chemotherapy. In recent years, the adve...
Autores principales: | Madoff, David C, Abi-Jaoudeh, Nadine, Braxton, David, Goyal, Lipika, Jain, Dhanpat, Odisio, Bruno C, Salem, Riad, Schattner, Mark, Sheth, Rahul, Li, Daneng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526481/ https://www.ncbi.nlm.nih.gov/pubmed/35925597 http://dx.doi.org/10.1093/oncolo/oyac139 |
Ejemplares similares
-
Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise
por: Saha, Supriya K., et al.
Publicado: (2016) -
Integrated prognostication of intrahepatic cholangiocarcinoma by contrast-enhanced computed tomography: the adjunct yield of radiomics
por: Silva, Mario, et al.
Publicado: (2021) -
Textbook oncologic outcomes and regionalization among patients undergoing hepatic resection for intrahepatic cholangiocarcinoma
por: Munir, Muhammad M., et al.
Publicado: (2022) -
Prediction of regional lymph node metastasis in intrahepatic cholangiocarcinoma: it’s not all about size
por: Kolck, Johannes, et al.
Publicado: (2023) -
Nomogram based on MRI for preoperative prediction of Ki-67 expression in patients with intrahepatic mass cholangiocarcinoma
por: Chen, Xiang, et al.
Publicado: (2022)